作者
Tian‐Hua Wei,Zixuan Wang,Meng‐Yi Lu,Yujing Xu,Jin Yang,Xing-Feng Ni,Cheng Yang,Mengyuan Zhang,Jia‐Chuan Liu,Qingqing Li,Jiao Cai,Zijun Chen,Ji-Bo Kang,Nan Li,Wei‐Chen Dai,Ning Ding,Yan‐Cheng Yu,Xuejiao Leng,Xin Xue,Xiao-Long Wang,Shan‐Liang Sun,Ye Yang,Nian‐Guang Li,Zhi‐Hao Shi
摘要
The FLT3-ITD (internal tandem duplication) mutant has been a promising target for acute myeloid leukemia (AML) drug discovery but is now facing the challenge of resistance due to point mutations. Herein, we have discovered a type II FLT3 inhibitor,
tianzml0
oceanao
含蓄的明雪
不配.
吃不饱星球球长
苏卿
嗯哼
Singularity
薰硝壤
彭于彦祖
哎嘿
pcr163
甜甜玫瑰
暮霭沉沉
互助遵法尚德
不安青牛
从容芮
iNk
Henry
遥远的尧
皖公网安备34019202002308
